Pfizer (PFE) Other financing activities (2016 - 2025)
Historic Other financing activities for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to -$38.0 million.
- Pfizer's Other financing activities rose 9164.84% to -$38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$870.0 million, marking a year-over-year increase of 563.99%. This contributed to the annual value of -$469.0 million for FY2024, which is 2567.35% up from last year.
- According to the latest figures from Q3 2025, Pfizer's Other financing activities is -$38.0 million, which was up 9164.84% from -$21.0 million recorded in Q2 2025.
- In the past 5 years, Pfizer's Other financing activities registered a high of $154.0 million during Q3 2022, and its lowest value of -$610.0 million during Q2 2021.
- Moreover, its 5-year median value for Other financing activities was -$162.5 million (2021), whereas its average is -$208.3 million.
- As far as peak fluctuations go, Pfizer's Other financing activities crashed by 112972.97% in 2024, and later skyrocketed by 9164.84% in 2025.
- Pfizer's Other financing activities (Quarter) stood at -$185.0 million in 2021, then plummeted by 84.86% to -$342.0 million in 2022, then soared by 94.74% to -$18.0 million in 2023, then plummeted by 2427.78% to -$455.0 million in 2024, then surged by 91.65% to -$38.0 million in 2025.
- Its Other financing activities was -$38.0 million in Q3 2025, compared to -$21.0 million in Q2 2025 and -$356.0 million in Q1 2025.